Recursion Pharmaceuticals, Inc. (RXRX)
NASDAQ: RXRX · Real-Time Price · USD
5.91
-0.18 (-2.96%)
At close: Oct 9, 2025, 4:00 PM EDT
6.09
+0.18 (3.05%)
Pre-market: Oct 10, 2025, 7:38 AM EDT
Recursion Pharmaceuticals Revenue
Recursion Pharmaceuticals had revenue of $19.22M in the quarter ending June 30, 2025, with 33.34% growth. This brings the company's revenue in the last twelve months to $64.60M, up 30.14% year-over-year. In the year 2024, Recursion Pharmaceuticals had annual revenue of $58.84M with 32.00% growth.
Revenue (ttm)
$64.60M
Revenue Growth
+30.14%
P/S Ratio
32.92
Revenue / Employee
$80,745
Employees
800
Market Cap
2.58B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 58.84M | 14.26M | 32.00% |
Dec 31, 2023 | 44.58M | 4.73M | 11.88% |
Dec 31, 2022 | 39.84M | 29.67M | 291.46% |
Dec 31, 2021 | 10.18M | 6.22M | 156.89% |
Dec 31, 2020 | 3.96M | 1.64M | 70.85% |
Dec 31, 2019 | 2.32M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 422.82B |
Johnson & Johnson | 90.63B |
Merck & Co. | 63.62B |
AbbVie | 58.33B |
AstraZeneca | 56.50B |
Novartis AG | 55.19B |
Eli Lilly and Company | 53.26B |
Novo Nordisk | 49.11B |
RXRX News
- 1 day ago - What's Going On With Recursion Pharmaceuticals Stock On Wednesday? - Benzinga
- 4 weeks ago - Recursion Pharmaceuticals, Inc. (RXRX) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference (Transcript) - Seeking Alpha
- 5 weeks ago - Recursion Pharmaceuticals, Inc. (RXRX) Presents At Citi's Biopharma Back To School Conference Transcript - Seeking Alpha
- 6 weeks ago - Recursion to Participate in Upcoming Investor Conferences - GlobeNewsWire
- 2 months ago - Recursion Pharmaceuticals, Inc. (RXRX) Q2 2025 Earnings Call Transcript - Seeking Alpha
- 2 months ago - Recursion Reports Second Quarter 2025 Financial Results and Provides Business Update - GlobeNewsWire
- 2 months ago - Recursion to Report Second Quarter 2025 Business Updates and Financial Results on August 5th - GlobeNewsWire
- 2 months ago - How Palantir, Tempus, Nvidia-Backed Recursion Are Disrupting Big Pharma - Benzinga